Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related INGR
Benzinga's Top Upgrades, Downgrades For May 4, 2018
Earnings Scheduled For May 3, 2018
Related REGN
Crispr Therapeutics Falls As Studies Suggest Possible Cancerous Side Effect
The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines

Analysts at Credit Suisse initiated coverage on shares of Ingredion (NYSE: INGR) with an “outperform” rating. The target price for Ingredion is set to $80. Ingredion's shares closed at $67.10 yesterday.

Canaccord Genuity initiated coverage on shares of Regeneron Pharmaceuticals (NASDAQ: REGN) with a “buy” rating. The target price for Regeneron Pharmaceuticals is set to $350. Regeneron Pharma's shares closed at $288.08 yesterday.

Morgan Stanley initiated coverage on shares of A10 Networks (NYSE: ATEN) with an “equal-weight” rating. A10 Networks' shares closed at $14.47 yesterday.

Analysts at Sterne Agee initiated coverage on shares of Actavis (NYSE: ACT) with a “buy” rating. The target price for Actavis is set to $230. Actavis' shares closed at $193.94 yesterday.

Latest Ratings for INGR

DateFirmActionFromTo
May 2018Credit SuisseMaintainsOutperformOutperform
May 2018BMO CapitalMaintainsMarket PerformMarket Perform
May 2018CitigroupDowngradesBuyNeutral

View More Analyst Ratings for INGR
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ACT + ATEN)

View Comments and Join the Discussion!